Informationen aus Orthodontie & Kieferorthopädie 2010; 42(1): 35-40
DOI: 10.1055/s-0030-1247288
Übersichtsartikel

© Georg Thieme Verlag Stuttgart ˙ New York

Schmelzmatrixproteine als prä-kieferorthopädische Therapie bei vertikalen Knochendefekten

Enamel Matrix Proteins as Pre-Orthodontic Therapy for Intrabony DefectsK. Bertl1 , M. Laky1 , M. Matejka1
  • 1Abteilung für Parodontologie und Prophylaxe, Medizinische Universität Wien, Österreich
Further Information

Publication History

Publication Date:
12 April 2010 (online)

Zusammenfassung

Dieser Beitrag liefert einen Überblick über Herkunft, Wirkung und Einsatzmöglichkeiten von Schmelzmatrixproteinen. Mittels eines Fallberichts wird deren Anwendung zur Therapie eines vertikalen Knochendefektes beschrieben. Wobei nach konservativer parodontaler Therapie und ­einer Optimierung der häuslichen Mundhygiene durch den regenerativen Eingriff mit Schmelzmatrixproteinen eine deutliche Verbesserung der Sondierungstiefe und des radiologischen Attachmentniveaus erzielt werden konnte. Des Wei­teren werden die Möglichkeiten der parodontal ­regenerativen Therapie vor einer geplanten kieferorthopädischen Therapie diskutiert.

Abstract

This report contains a review on the derivation, impact and possible applications of enamel matrix proteins. A case report shows the application of enamel matrix proteins in the therapy of an ­intrabony defect. After scaling and root planing and optimising the oral plaque hygiene, the prob­ing pocket depth and the radiological attachment ­level was improved with regenerative periodon­tal surgery and the application of enamel ma­trix proteins. Additionally, a short statement on the combined periodontal-orthodontic treatment with enamel matrix proteins is made.

Literatur

  • 1 Albandar J, Brunelle J, Kingman A. Destructive periodontal disease in adults 30 years of age and older in the United States, 1988–1994.  J Peri­odontol. 1999;  70 13-29
  • 2 Foster B, Somerman M. Regenerating the periodontium: is there a ­magic formula?.  Orthod Craniofac Res. 2005;  8 285-291
  • 3 Gestrelius S, Andersson C, Lidstrom D et al. In vitro studies on periodontal ligament cells and enamel matrix derivative.  J Clin Periodontol. 1997;  24 685-692
  • 4 Hammarstrom L. Enamel matrix, cementum development and regeneration.  J Clin Periodontol. 1997;  24 658-668
  • 5 Venezia E, Goldstein M, Boyan B et al. The use of enamel matrix derivative in the treatment of periodontal defects: a literature review and meta-analysis.  Crit Rev Oral Biol Med. 2004;  15 382-402
  • 6 Bertl K, An N, Bruckmann C et al. Effects of enamel matrix derivative on proliferation / viability, migration, and expression of angiogenic factor and adhesion molecules in endothelial cells in vitro.  J Periodontol. 2009;  80 1622-1630
  • 7 Kawase T, Okuda K, Momose M et al. Enamel matrix derivative (EMDOGAIN) rapidly stimulates phosphorylation of the MAP kinase family and nuclear accumulation of smad2 in both oral epithelial and fibroblastic human cells.  J Periodontal Res. 2001;  36 367-376
  • 8 Kawase T, Okuda K, Yoshie H et al. Anti-TGF-beta antibody blocks ­enamel matrix derivative-induced upregulation of p21WAF1 / cip1 and prevents its inhibition of human oral epithelial cell proliferation.  J Periodontal Res. 2002;  37 255-262
  • 9 Suzuki S, Nagano T, Yamakoshi Y et al. Enamel matrix derivative gel stimulates signal transduction of BMP and TGF-{beta}.  J Dent Res. 2005;  84 510-514
  • 10 Cattaneo V, Rota C, Silvestri M et al. Effect of enamel matrix derivative on human periodontal fibroblasts: proliferation, morphology and root surface colonization. An in vitro study.  J Periodontal Res. 2003;  38 568-574
  • 11 Zetterstrom O, Andersson C, Eriksson L et al. Clinical safety of enamel matrix derivative (EMDOGAIN) in the treatment of periodontal defects.  J Clin Periodontol. 1997;  24 697-704
  • 12 Sculean A, Junker R, Donos N et al. Immunohistochemical evaluation of matrix molecules associated with wound healing following treatment with an enamel matrix protein derivative in humans.  Clin Oral Investig. 2003;  7 167-174
  • 13 Heijl L. Periodontal regeneration with enamel matrix derivative in one human experimental defect. A case report.  J Clin Periodontol. 1997;  24 693-696
  • 14 Hagenaars S, Louwerse P, Timmerman M et al. Soft-tissue wound healing following periodontal surgery and Emdogain application.  J Clin Periodontol. 2004;  31 850-856
  • 15 Fickl S, Thalmair T, Kebschull M et al. Microsurgical access flap in conjunction with enamel matrix derivative for the treatment of intra-bony defects: a controlled clinical trial.  J Clin Periodontol. 2009;  36 784-790
  • 16 Giannobile W, Somerman M. Growth and amelogenin-like factors in periodontal wound healing. A systematic review.  Ann Periodontol. 2003;  8 193-204
  • 17 Heijl L, Heden G, Svardstrom G et al. Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects.  J Clin Peri­odontol. 1997;  24 705-714
  • 18 Sculean A, Donos N, Windisch P et al. Healing of human intrabony ­defects following treatment with enamel matrix proteins or guided tissue regeneration.  J Periodontal Res. 1999;  34 310-322
  • 19 Sculean A, Berakdar M, Willershausen B et al. Effect of EDTA root con­ditioning on the healing of intrabony defects treated with an enamel matrix protein derivative.  J Periodontol. 2006;  77 1167-1172
  • 20 Esposito M, Grusovin M, Papanikolaou N et al. Enamel matrix deriva­tive (Emdogain(R)) for periodontal tissue regeneration in intrabony ­defects. Cochrane Database Syst Rev 2009; CD003875
  • 21 Ericsson I, Thilander B, Lindhe J et al. The effect of orthodontic tilting movements on the periodontal tissues of infected and non-infected dentitions in dogs.  J Clin Periodontol. 1977;  4 278-293
  • 22 Mathews D, Kokich V. Managing treatment for the orthodontic patient with periodontal problems.  Semin Orthod. 1997;  3 21-38
  • 23 Re S, Corrente G, Abundo R et al. Orthodontic treatment in periodon­tally compromised patients: 12-year report.  Int J Periodontics Restorative Dent. 2000;  20 31-39
  • 24 Zachrisson B. Clinical implications of recent orthodontic-periodontic research findings.  Semin Orthod. 1996;  2 4-12
  • 25 Juzanx I, Giovannoli J. Kieferorthopädisch verursachter Gewebeumbau und parodontale Heilung.  Parodontologie. 2007;  18 203-211
  • 26 Polson A, Caton J, Polson A P et al. Periodontal response after tooth movement into intrabony defects.  J Periodontol. 1984;  55 197-202
  • 27 Ghezzi C, Masiero S, Silvestri M et al. Orthodontic treatment of peri­odontally involved teeth after tissue regeneration.  Int J Periodontics Restorative Dent. 2008;  28 559-567
  • 28 Cardaropoli D, Re S, Corrente G et al. Reconstruction of the maxillary midline papilla following a combined orthodontic-periodontic treatment in adult periodontal patients.  J Clin Periodontol. 2004;  31 79-84
  • 29 Diedrich P, Fritz U. Zahnbewegung nach gesteuerter Geweberegeneration.  Kieferorthopädie. 2004;  18 265-275
  • 30 Diedrich P, Fritz U, Kinzinger G et al. Movement of periodontally affect­ed teeth after guided tissue regeneration (GTR) – an experimental pilot study in animals.  J Orofac Orthop. 2003;  64 214-227
  • 31 Wennstrom J, Stokland B, Nyman S et al. Periodontal tissue response to orthodontic movement of teeth with infrabony pockets.  Am J Orthod Dentofacial Orthop. 1993;  103 313-319

K. Bertl

Bernhard Gottlieb Universitätszahnklinik · Abteilung für Parodontologie und Prophylaxe

Währingerstr. 25 a

A-1090 Wien

Email: kristina.bertl@meduniwien.ac.at